Request Demo
Last update 23 Jan 2025
Diphenhydramine Hydrochloride/Ibuprofen
Last update 23 Jan 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Ibuprofen/Diphenhydramine Hydrochloride, 复方布洛芬缓释片(越洋医药) + [1] |
Target |
Mechanism COX inhibitors(Cyclooxygenases inhibitors), H1 receptor inverse agonists(Histamine H1 receptor inverse agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (21 Dec 2005), |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaC13H18O2 |
InChIKeyHEFNNWSXXWATRW-UHFFFAOYSA-N |
CAS Registry15687-27-1 |
View All Structures (2)
Related
2
Clinical Trials associated with Diphenhydramine Hydrochloride/IbuprofenCTR20222851
复方布洛芬多释片在健康受试者中的随机、开放、两周期、双交叉空腹状态下比较药代动力学试验。
[Translation] A randomized, open-label, two-period, double-crossover comparative pharmacokinetic study of ibuprofen extended-release compound tablets in healthy subjects under fasting conditions.
NCT05674721
A Randomized, Open Label, Single Center, Single Dose, Two Treatment, Two Period, Two Sequence Crossover Bioequivalence Study of Advil PM Liqui-Gels Minis (Ibuprofen/Diphenhydramine Hydrochloride 200 mg/25 mg) To Advil PM Liqui-Gels (Ibuprofen/Diphenhydramine Hydrochloride 200 mg/25 mg) in Healthy Adult Subjects Under Fasted Conditions
100 Clinical Results associated with Diphenhydramine Hydrochloride/Ibuprofen
Login to view more data
100 Translational Medicine associated with Diphenhydramine Hydrochloride/Ibuprofen
Login to view more data
100 Patents (Medical) associated with Diphenhydramine Hydrochloride/Ibuprofen
Login to view more data
100 Deals associated with Diphenhydramine Hydrochloride/Ibuprofen
Login to view more data
R&D Status
Approved
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Sleep Initiation and Maintenance Disorders | US | 21 Dec 2005 |
Developing
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Pain | Phase 1 | CN | 28 Nov 2022 | |
| Sleep Initiation and Maintenance Disorders | Phase 1 | CN | 28 Nov 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 1 | 77 | Advil PM Liqui-Gels+ibuprofen+diphenhydramine hydrochloride (Treatment A (Test)) | kdzwdbicmv(zasaqvizux) = ubzdcfwboh ayuuzttvfv (bsoghtshit, jpmrqtajao - pnhwfpzdyw) View more | - | 23 Aug 2024 | ||
Advil PM Liqui-Gels+ibuprofen+diphenhydramine hydrochloride (Treatment B (Reference)) | kdzwdbicmv(zasaqvizux) = nsiyoupcnr ayuuzttvfv (bsoghtshit, vtzytyoxci - bhlaeqzldo) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free